Navigation Links
A 'fat forward' research tool
Date:5/6/2010

Anglers rely on fish finders to help them locate the big catch. Now Tel Aviv University researchers in tissue engineering have developed a "fat finder" that can help scientists accelerate their research into new fat-melting drugs.

The new software-based tool, reported in a recent issue of the journal Tissue Engineering, fits onto a microscope like a pair of goggles and allows a scientist to measure a broad number of physical parameters in the Petri dish while investigating fat cells. They might explore how fat cells change when given insulin, or how they react when treated with new experimental drug compounds. Normally these kinds of questions need to be investigated with intensive pre-clinical and clinical trials an expensive and time-consuming process.

With the tool he invented, Prof. Amit Gefen of Tel Aviv University's Faculty of Engineering is able to address these questions at the cellular level by looking at individual fat cells to see what happens to them under experimental conditions. The tool allows scientists to see and assess quickly what is happening to each cell, and how individual cells change over time. Until now, fat tissues were studied as a whole, with little knowledge as to how cells react one by one. But a look at individual cells gives clues about the toxicity or effectiveness of a treatment almost immediately.

Cell squats and push-ups

Prof. Gefen's new research looks at lab-engineered fat cells. "Good for studying fat, the 'fat finder' is also a general purpose tool. It can save researchers time and money and help them answer questions in basic research and drug design," he says.

Prof. Gefen's tool gives scientists the ability to accurately measure what happens in live cell cultures over time. Equipped with algorithms to measure baseline cellular activity and compare it to how cells being experimented on behave, his device helps understand how fat tissue develops, so that "optimal" tissue-engineered fat can be produced as a biological substitute for treating wounds and in plastic surgery procedures.

Prof. Gefen is now adding other components to the microscope, such as a laser-based scan that can see cell slices in three dimensions. From these slices, he can make a computer model of the actual cell. Once the cell is "inside" the computer, it can be stretched and compressed mechanically via software controls under very specific parameters.

This tells Prof. Gefen how fat cells in different parts of the body react to pressure due to immobility, for example. "Our starting point is the chronic wounds field, but if you're a brain researcher, you can use it to see how neurons respond to pressure," he says.

Tissue made to order

Dr. Gefen's interrelated tools open up many possibilities for basic biological research and drug development. Researchers will be able to "see" details of cellular events that can't be described by other methods. And the tools can help investigators planning drug studies and clinical trials to implement well-controlled and efficient tissue engineering protocols and experiments.

Until now Prof. Gefen's engineered fat cell cultures and software tool have been tested using animal cells, but Prof. Gefen plans to do similar studies based on human fat cells. In addition to helping drug developers come up with more effective anti-obesity drugs, Prof. Gefen's research seeks to know more about paraplegics and how their weight gain affects other cells and body processes. With this information in hand, he hopes to be able to devise better injury prevention and treatment regimens.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Related biology news :

1. Meteosat Third Generation takes a step forward
2. First adhere, then detach and glide forward
3. Step forward for nanotechnology: Controlled movement of molecules
4. Another JDRF partner moves research forward with collaboration agreement for diabetes treatment
5. Clinical trials for shingles drug take an important step forward
6. Moving gene therapy forward with mobile DNA
7. How to move agriculture forward with limited water
8. New technique is quantum leap forward in understanding proteins
9. Forward planning release from the BA
10. Large-scale investment catapults CAMHs mental illness and addiction research forward
11. New step forward in search for solution to infection puzzle
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A 'fat forward' research tool
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
Breaking Biology Technology: